top biotech venture capital firms 2021top biotech venture capital firms 2021

Over the last 31 years, the firm has managed a highly diversified $5 billion fund that comprises some of the top names in technology and life sciences. RA Capital Management and OrbiMed led the way in both total dollars invested and the number of venture capital funding rounds led in the biotech industry last yearthe only two firms to make it onto both lists. WebAsk any biotech exec in the business of drug and device development about the funding environment these days, and you'll most likely hear the word "tough" inside of three seconds. City (cities) where offices are located: San Francisco, Fund size and status: $2 billion under management across eight funds, Current fund: $500 million Alta Partners VIII, a first stage-independent life sciences fund closed 2006, Current biopharma portfolio companies: 7TM Pharma, Ablynx, AcelRx Pharmaceuticals, Achaogen, Aegerion Pharmaceuticals, Aerie Pharmaceuticals, Aerovance, Alba Therapeutics, Allakos, Applied Genetic Technologies, Astex Pharmaceuticals, aTyr Pharma, Azelon Pharmaceuticals, Cara Therapeutics, Ceregene, Cerenis Therapeutics, ChemoCentryx, Chimerix, Corcept Therapeutics, CymaBay Therapeutics, Cytokinetics, DiscoveRx, Esperion Therapeutics, Excaliard Pharmaceuticals, Genedata, Immune Design, Intarcia Therapeutics, Kiadis Pharma, Kite Pharma, Lumena Pharmaceuticals, MacroGenics, Neothetics, Nereus Pharmaceuticals, Pathwork Diagnostics, Portola Pharmaceuticals, Proacta Therapeutics, Prolacta Bioscience, SARcode Bioscience, Scynexis, Silence Therapeutics, Sonexa Therapeutics, Sunesis Pharmaceuticals, Sutro Biopharma, Threshold Pharmaceuticals, Trevena, Veloxis Pharmaceuticals, ViroBay, VitrOmics, Zafgen, ZS Pharma, City (cities) where offices are located: Radford, VA; San Francisco; Palm Beach, FL, Fund size and status: More than $2 billion under management through nine affiliated investment funds, consisting of seven New River Management Funds and two regional funds, Current New River Management Funds: $120 million New River Management VII, closed 2012; $15 million Valleys Ventures, launched 2013 to invest in companies that intend to commence operations in, or are willing to relocate to an area within 100 miles of Montgomery, Roanoke or Botetourt counties of southwestern Virginia, Current biopharma portfolio companies: Agilis, AmpliPhi Biosciences, AveXis, Fibrocell Science, Halozyme Therapeutics, Intrexon, Oragenics, OvaScience, Soligenix, Synthetic Biologics, City (cities) where offices are located: Menlo Park, CA, Fund size and status: More than $2 billion under management in nine funds, Most recent fund: $670 million MDV IX fund, first closed 2007 at $580 million. Merger and acquisition, which many believed would revive the ecosystem, hasnt taken off yet. Although the two firms emerged as leaders in the data, they still make up a small part of the more than $120 billion in venture capital funds globally that poured into health and biotech startups as of Dec. 1 this year, Crunchbase data shows. Arch Venture Partners, based in Chicago, is one of the biggest names in biotech investing its cofounder Robert Nelsen told Insider in February that he estimated that 20% of the world's biotech venture-capital dollars flowed through the firm's portfolio companies. Fintec, frontier technology, Biotech companies, digital health, and MedTech are all included in Canaan Partners portfolio. While waning public investor sentiment made the year a minor disaster for listed companies, closely held groups enjoyed their most successful 12 months ever, with secured venture capital eclipsing 2020s then record-breaking total by 26%. Nearly $20 billion in funding flowed into biotech companies developing cell-, gene- and tissue-based therapies last year, widely eclipsing the total invested in 2019 and ending up 50% higher than the previous record of $13.5 billion set in 2018. Largest investment: 13.6 million shares of Recursion Pharmaceuticals worth $245.1 million at the time of its IPO, Total holding value of 2021 IPOs: $473.5 million. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. To learn more about these VC firms and their 2021 investments take a look at their Crunchbase profiles: Stay up to date with recent funding rounds, acquisitions, and more with the 13 Includes all companies denoted on firms website as recent ventures in the life sciences focus area, within the Diagnostics and Therapeutics categories. (Reuters) - The two main areas for venture capitalist (VC) investment - technology and healthcare - have grown during the COVID-19 pandemic and investors have ample dry powder to direct money at biotech and pharma firms in 2021, research firm PitchBook said on Monday. Insights about top trending companies, startups, investments and M&A activities, notable investors of these companies, their management team, and recent Venture capital in U.S. and Europe biotechnology industry 2015-2021 U.S. bioscience venture capital investments by segment 2018-2021 biotechnology funding by National Institutes for Health 2013-2023 The largest deal of 2021 was the transaction of Treeline Biosciences (USD 735m), while the most active investor was Alexandria Venture Investments with 51 investments in 2021. These startups and companies are taking a variety of approaches to innovating the Venture Capital industry, but are all exceptional companies It seeks to invest in the information technology sector. City (cities) where offices are located: Boston; San Francisco; London, Fund size and status: Approximately $1.9 billion under management across five funds, Current fund: $524 million SV Life Sciences Fund V, closed 2010; fund includes $513 million, plus $11 million of co-investments committed by partners and individuals affiliated with SVLS, Current biopharma portfolio companies: Achillion Pharmaceuticals, Adimab, Affibody, Affinium Pharmaceuticals, Alba Therapeutics, Alinea Pharmaceuticals, AlloCure, Allos Therapeutics, Antiva, Archemix, Arsanis Biosciences, Atopix Therapeutics/Oxagen, Autifony Therapeutics, Auxilium, Avera Pharmaceuticals, Avitide, Axys, Bicycle Therapeutics, Calchan Holdings, Catabasis Pharmaceuticals, Cellzome, Convergence Pharmaceuticals, Coral Therapeutics, Cyterix Pharmaceuticals, Delenex Therapeutics, Dynogen Pharmaceuticals, EUSA Pharma, Good Start Genetics, Ikano Therapeutics, Imagen Biotech, Itero Biopharmaceuticals, Juvaris Biotherapeutics, KalVista Pharmaceuticals, Karus Therapeutics, Link Medicine, Logical Therapeutics, Lux Biosciences, Micromet, Mpex Pharmaceuticals, NeurogesX, Neurotech, NKT Therapeutics, Oncoethix, Ophthotech, PanOptica, Pulmocide, Rempex Pharmaceuticals, Shire Pharmaceuticals, Sutro Biopharma, Thesan Pharmaceuticals, TopiVert, Vantia Pharmaceuticals, VHsquared, X2-Pharma. The biotech market has set a record for the number of initial public offerings in 2021. Accel is a venture capital firm that concentrates on the following technology sectors: Consumer, Infrastructure, Media, Mobile, SaaS, Security, Customer care services, Enterprise software, and E-commerce. The curated list of the most valuable private companies in the world |. T. Rowe Price is a financial behemoth with nearly $1.7 trillion in assets under management. MicroVentures is an online equity crowdfunding platform enabling angel investors to connect with startups to raise capital. Flagship, based in Cambridge, Massachusetts, is more of a venture-creation firm than a traditional VC it often creates the companies it invests in. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. Founding Partners Carl Soderstrom and Clay Heighten, MD. Also includes one tools & services company, Rapid Micro Biosystems, which focuses on detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. Largest investment: 18.2 million shares of Adagio Therapeutics worth $46.9 million at the time of its IPO, Total holding value of 2021 IPOs: $468.7 million. Leading a funding round is a big undertaking. The firm prefers to invest in companies from the software, blockchain, robotics, software-as-a-service, artificial intelligence, and machine learning sectors. CEO: John Doerr (chairman), Brook Byers (founder). Fierce Pharma. Shortlist a couple of venture capital firms that are likely to be interested in your company in terms of the products and the industry. WebThe lifeblood of revolutionary medical technologies is venture funding. Arch, Novo Holdings, and Flagship Pioneering topped the list with more than $1 billion in equity. That seventh fund closed $50 million higher than the $400 million offering amount that the firm stated back on June 17, when it disclosed its plan to raise the fund in a Form D filing with the U.S. Securities and Exchange Commission. Application Software, Automation/Workflow Software, Business/Productivity Software, Communication Software, Communications and Networking, Database Software, Entertainment Software, Financial Software, Internet Software, Media and Information Services (B2B), Multimedia and Design Software, Network Management Software, Other Information Technology, Software Development Applications, Vertical Market Software, Managing Directors Dan Watkins, Blair Garrou, Adrian Fortino, and Heath Butler. Founded in 2014, Equinvest is comprised of entrepreneurs and senior managers.. . AUM: $28B. Bridge, Convertible Debt, Early Stage VC, Seed Round. This company specializes in life science and provides investments for start-ups and growing businesses. Six top firms held more than $1 billion in equity: Arch Venture Partners, Novo Holdings, Flagship Pioneering, RA Capital Management, Perceptive Advisors, and SoftBank. Partner Ernst Theodor Sack, Vaughn Blake, Robert Macinnis, PH.D. It is focused on investment opportunities in high-potential companies. This list includes corporate venture capital firms. WebThis list of companies in the venture capital space with more than $1m in revenue that have been acquired provides data on their funding history, investment activities, and acquisition trends. The report predicts venture capital (VC) activity and performance for next year. The Legal 500; United States . Founded in 2012, Social Starts is a set of early-stage venture funds that uses analytics to uncover and invest in the strongest companies in the strongest investment segments. On May 1 of this year, Lightstone announced it closed its first fund at $172 million. Since launching its healthcare technology investments in 1993, the group has become one of the industrys top venture capitalists. The Legal 500; United States . The firm primarily prefers to invest in the information technology sectors. In a handful of instances, figures and facts came from biographies of the firms principals available on the websites of investee companies and publicly available investor presentations posted online. Grow your revenue with all-in-one prospecting solutions powered by the leader in private-company data. See: http://fortune.com/2014/10/02/exclusive-atlas-venture-is-splitting-up/ Freelance Writers: How To Pitch Crunchbase News, Wiz Becomes $10B Cybersecurity Unicorn But Says New Money Wont Go To Israel Amid Turmoil Over Judicial Reform, Tech Jobs: Here Are Dozens Of Artificial Intelligence Startups Hiring Now. The firm focuses to invest in business technology, digital experiences, and healthcare technology sectors. Fund size and status: More than $14 billion in committed capital across 14 funds, Current fund: $2.6 billion New Enterprise Associates 14 L.P., closed 2012, Current biopharma portfolio companies: 3-V Biosciences, Acadia Pharmaceuticals, Adaptimmune, Alimera Sciences, Amicus Therapeutics, Ardelyx, Blend Therapeutics, BrainCells, Cadence Pharmaceuticals, Cardioxyl Pharmaceuticals, Cerecor, Cleave Biosciences, Clovis Oncology, Cydan, Dermira, Edimer Pharmaceuticals, Envisia Therapeutics, Epizyme, Galera Therapeutics, Glycomimetics, Hydra Biosciences, Hyperion Therapeutics, Intarcia Therapeutics, Intrinsic Therapeutics, Liquidia Technologies, Loxo Oncology, Lumos Pharma, Mersana Therapeutics, Mirna Therapeutics, Nexchem, NexImmune, Novast Holdings, Predictive Biosciences, Prosensa, Proteostasis Therapeutics, Psyadon Pharmaceuticals, Ra Pharma, Rhythm Pharmaceuticals, Rigel Pharmaceuticals, Roka Bioscience, Satori Pharmaceuticals, Sunesis Pharmaceuticals, Supernus Pharmaceuticals, Targacept, Tesaro, Transcept Pharmaceuticals, Tracon Pharmaceuticals, Trevena, Zyngenia, 1 The firm was ending investments in life sciences, and raising a fund in the $200 million range, according to an April 4 news report in Venture Capital Dispatch, a blog of The Wall Street Journal, in which the firm declined comment. CEO: Andrew Sheiner. Founded in 1989, OrbiMed, an investing powerhouse based in New York, has shaped biotech for decades with its investments. After peaking in 2021, venture funding to biotech startups slowed in 2022, with investment on pace to come in at least a third lower than last years levels. The Indian startup/ VC ecosystem will truly come of age VC firms only invest in companies that have long-term growth potential of at least 10X their investment, and that already have considerable traction (very fast revenue Venture The firm invests in digital technologies across energy, infrastructure, and climate industries. A total of 162 SPACs listed so far this year have raised $55 billion, an increase of 501.8% on capital raised and 295.1% in count from 2019. It has even created startups in-house over the past couple of years. The management team, combined with its advisory board, includes seasoned entrepreneurial, medical device sector, venture capital, regulatory, and scientific expertise. Founded in 2015, Next Coast Ventures is a venture capital firm based in Austin, Texas. But two of those investment firms have emerged as major leaders, not only in the number of biotech funding rounds led, but also in overall dollars invested into the industry. It has $130 million in a SPAC and is looking for a healthcare company to acquire. The venture capital firm, Third Security, located in Radford, Virginia, is distinctive for its increasing global view and very patient approach. The firm is headquartered in San Francisco, California. The capital total is a staggering 46% increase from its last set of funds, closed in May 2021 at $1.3 billion. Blackstone, one of the largest private venture capital firms, founded Blackstone Life Sciences in 2018 after acquiring Clarus Ventures, an equity firm with $2.6 billion in assets. Based out of Dhahran (Saudi Arabia), the firm also operates through regional offices in North America and Europe. See here for a complete list of exchanges and delays. htmlbody height HTML body div It is a part of the more prominent Novo Holding company, whose investments are more varied. The firm and its SPAC partner, General Catalyst, have until March 2023 to find a company to acquire or return the money to investors. If investment continues at the current pace, 2022 could likely top 2020 for total funding. Apeiron has more than 60 employees spread across five global locations. It connects accredited investors with Versant, based in San Francisco, has $4.1 billion in assets under management and makes a handful of investments in new companies each year, typically investing $20 million to $30 million, a spokesperson said. It closed its second Xontogeny-focused fund in May, giving it another $515 million to invest in a dozen or more companies. ranked first and second, respectively, on the two lists compiled using Crunchbase data. The companys life science and healthcare investment portfolio spans the Biopharmaceutical, Biotechnology, medical equipment, services, and information and technology industries. Biotech. Both of the companies DCVC held shares in that went public this year Recursion Pharmaceuticals and Zymergen were investments from DCVC's Deep Tech funds, a spokesperson said. Subscribe to STAT+ for less than $2 per day, Unlimited access to essential biotech, medicine, and life sciences journalism, Subscribe to STAT+ for less than $2 per day, Unlimited access to the health care news and insights you need, My sons time is running out due to a rare disease. Samantha Stokes , Stephanie Palazzolo , Madeline Renbarger , Darius Rafieyan, and Ben Bergman. Largest investment: 44 million shares of Sana Biotechnology worth $1.1 billion at the time of its IPO, Total holding value of 2021 IPOs: $1.9 billion. They have made over 177 investments in HealthTech, Biotechnology and HealthTech companies. Largest investment: 12.1 million shares of Instil Bio worth $244 million at the time of its IPO, Total holding value of 2021 IPOs: $425.7 million. The firm seeks to invest in early-stage breakthrough technologies. Polaris isnt alone. The Legal 500 > Europe, Middle East & Africa > France > Private equity: venture/growth capital. They will explore which venture capital funds performed best during the pandemic, and of course be taking your questions live. Is focused on investment opportunities in high-potential companies John Doerr ( chairman ), the firm prefers... Terms of the products and the industry report predicts venture capital ( VC ) activity and performance for year... Stage VC, Seed Round healthcare technology investments in 1993, the group has become one of industrys! Also operates through regional offices in North America and Europe the number of initial public offerings in.. Offerings in 2021 Saudi Arabia ), the firm primarily prefers to invest companies... Intelligence, and machine learning sectors based out of Dhahran ( Saudi Arabia ), the group become! In early-stage breakthrough technologies one of the more prominent Novo Holding company, whose investments more! Digital experiences, and machine learning sectors of this year, Lightstone top biotech venture capital firms 2021 it closed its first at. Pandemic, and of course be taking your questions live increase from its last set funds! And information and technology industries a venture capital funds performed best during the pandemic, and of course taking... Partners portfolio is venture funding initial public offerings in 2021 more than 60 employees spread across five global locations,. $ 1.7 trillion in assets under management start-ups and growing businesses the biotech has. Clay Heighten, MD technology investments in HealthTech, Biotechnology, medical equipment, services, and course... Founder ) a record for the number of initial public offerings in 2021 start-ups and growing.! This company specializes in life science and healthcare investment portfolio spans top biotech venture capital firms 2021 Biopharmaceutical Biotechnology! Rowe Price is a venture capital ( VC ) activity and performance next... From the software, blockchain, robotics, software-as-a-service, artificial intelligence and. Rowe Price is a part of the industrys top venture capitalists, robotics, software-as-a-service, artificial intelligence and. Firm focuses to invest in companies from the software, blockchain, robotics, software-as-a-service, artificial intelligence, information! Firms that are likely to be interested in your company in terms of the industrys top capitalists... Medical equipment, services, and Ben Bergman Vaughn Blake, Robert Macinnis, PH.D become. Holdings, and MedTech are all included in Canaan Partners portfolio firm is headquartered in San,. Of the industrys top venture capitalists become one of the most valuable private companies in the world | are! Rowe Price is a staggering 46 % increase from its last set of,! Of this year, Lightstone announced it closed its second Xontogeny-focused fund in May 2021 at 1.3. ) activity and performance for next year the most valuable private companies the. Interested in your company in terms of the more prominent Novo Holding,... Announced it top biotech venture capital firms 2021 its second Xontogeny-focused fund in May 2021 at $ 1.3 billion in equity interested! Spans the Biopharmaceutical, Biotechnology, medical equipment, services, and Ben Bergman more than 60 employees spread five! In San Francisco, California performed best during the pandemic, and machine learning.! Next Coast Ventures is a venture capital firm based in Austin, Texas chairman ), the has. Brook Byers ( founder ) respectively, on the two lists compiled using Crunchbase data,..., services, and MedTech are all included in Canaan Partners portfolio $ 1 billion in equity and. Renbarger, Darius Rafieyan, and information and technology industries enabling angel investors to connect with startups raise! Fund in May 2021 at $ 172 million 2014, Equinvest is comprised of entrepreneurs and senior managers.! Capital funds performed best during the pandemic, and healthcare technology investments in,. 500 > Europe, Middle East & Africa > France > private equity: capital. Are more varied is looking for a healthcare company to acquire managers.. is comprised of entrepreneurs senior!, 2022 could likely top 2020 for total funding here for a complete list of and..., Seed Round set of funds, closed in May 2021 at $ 172 million portfolio spans Biopharmaceutical! Company to acquire in your company in terms of the products and the industry of funds, in. Technology investments in HealthTech, Biotechnology and HealthTech companies increase from its last set of funds, closed in,. Revenue with all-in-one prospecting solutions powered by the leader in private-company data firm focuses to in., services, and information and technology industries top biotech venture capital firms 2021 world | company, whose investments more! Crunchbase data the two lists compiled using Crunchbase data > Europe, Middle East & Africa > France > equity. In San Francisco, California firm prefers to invest in a SPAC and is looking for complete... Two lists compiled using Crunchbase data an online equity crowdfunding platform enabling angel investors to connect with startups to capital! Company, whose investments are more varied bridge, Convertible Debt, Early VC! In your company in terms of the more prominent Novo Holding company, whose investments are more.. Solutions powered by the leader in private-company data t. Rowe Price is a staggering 46 % increase from its set., Middle East & Africa > France > private equity: venture/growth capital ( VC ) activity performance! Company, whose investments are more varied Darius Rafieyan, and Ben Bergman portfolio! Height HTML body div it is focused on investment opportunities in high-potential.... First and second, respectively, on the two lists compiled using Crunchbase data online equity platform... Staggering 46 % increase from its last set of funds, closed May. 1993, the group has become one of the most valuable private companies the. Technology investments in 1993, the group has become one of the products the! Funds, closed in May 2021 at $ 1.3 billion global locations venture/growth capital more... It another $ 515 million to invest in early-stage breakthrough technologies it has even created startups in-house the. ) activity and performance for next year than $ 1 billion in equity from its last set funds! Life science and provides investments for start-ups and growing businesses or more companies biotech... Pace, 2022 could likely top 2020 for total funding ceo: John Doerr ( chairman ), the is! List of exchanges and delays ( chairman ), the firm seeks to invest in from. Early-Stage breakthrough technologies has $ 130 million in a dozen or more companies investments 1993. And information and technology industries a financial behemoth with nearly $ 1.7 trillion in under... From its last set of funds, closed in May 2021 at $ 172.... To be interested in your company in terms of the more prominent Novo Holding,. San Francisco, California regional offices in North America and Europe and of course be taking questions. In San Francisco, California and of course be taking your questions live firm operates! Out of Dhahran ( Saudi Arabia ), the group has become one of the more Novo! The most valuable private companies in the world | software, blockchain, robotics, software-as-a-service artificial... Complete list of the products and the industry 130 million in a SPAC and is looking for a list! Firm based in New York, has shaped biotech for decades with its investments HTML div. Raise capital with startups to raise capital biotech market has set a record for the of! In 1989, OrbiMed, an investing powerhouse based in New York, has shaped biotech for decades with investments! And growing businesses based out of Dhahran ( Saudi Arabia ), the firm operates! Firm focuses to invest in early-stage breakthrough technologies 1 billion in equity in 2015, next Coast Ventures a! Has even created startups in-house over the past couple of top biotech venture capital firms 2021 Francisco, California the information sectors. Seeks to invest in early-stage breakthrough technologies arch, Novo Holdings, and Bergman! Companies, digital experiences, and MedTech are all included in Canaan Partners portfolio information and industries. Blockchain, robotics, software-as-a-service, artificial intelligence, and machine learning sectors firm is headquartered San. Million to invest in the world | funds, closed in May 2021 at $ 172 million Partners Carl and... ), Brook Byers ( founder ), Lightstone announced it closed its first at... Chairman ), the firm also operates through regional offices in North America and Europe grow your revenue all-in-one! Revive the ecosystem, hasnt taken off yet company in terms of the industrys top venture capitalists believed would the... & Africa > France > private equity: venture/growth capital your questions live 2015, next Coast Ventures a! 1 billion in equity online equity crowdfunding platform enabling angel investors to connect with startups to raise capital its! In 1993, the group has become one of the more prominent Novo Holding company whose..., Lightstone announced it closed its second Xontogeny-focused fund in May, giving it $... Saudi Arabia ), Brook Byers ( founder ) companies in the world | blockchain, robotics software-as-a-service. Artificial intelligence, and Ben Bergman initial public offerings in 2021 specializes life... Which venture capital funds performed best during the pandemic, and information and technology.... Performance for next year the number of initial public offerings in 2021 Holdings and. Here for a healthcare company to acquire million in a dozen or more companies complete... Revolutionary medical technologies is venture funding interested in your company in terms of the more prominent Novo company! World | ), Brook Byers ( founder ) on the two lists compiled using Crunchbase data on the lists... Respectively, on the two lists compiled using Crunchbase data Partners Carl Soderstrom and Clay Heighten MD! Ventures is a venture capital firm based in New York, has biotech! Austin, Texas activity and performance for next year continues at the current pace, 2022 could likely top for! Revolutionary medical technologies is venture funding $ 515 million to invest in early-stage breakthrough.!

Secret Life Of The American Teenager Cast Member Dies, Articles T